Archer Investment Corporation’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Archer Investment Corporation’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-570	Closed	-$23.9K	–	835
2022 Q2	$23.9K	Buy	570 +3	+0.5%	+$126	0.01%	438
2022 Q1	$25.5K	Sell	567 -5	-0.9%	-$220	0.01%	449
2021 Q4	$26.4K	Buy	572 +2	+0.4%	+$95	0.01%	453
2021 Q3	$27K	Buy	570 +1	+0.2%	+$50	0.01%	436
2021 Q2	$29.4K	Buy	569 +1	+0.2%	+$50	0.01%	382
2021 Q1	$28.6K	Buy	+568	New	+$30.3K	0.01%	416
2020 Q3	–	Sell	-420	Closed	-$18K	–	690
2020 Q2	$18K	Buy	420 +69	+20%	+$2.85K	0.01%	366
2020 Q1	$13K	Buy	+351	New	+$15K	0.01%	399

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Archer Investment Corporation's XPH Position: Q3 2022 in Review

Archer Investment Corporation sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2022, closing a stake of 570 shares — an estimated $23.9K sold.

Archer Investment Corporation first reported a position in XPH in Q1 2020 and held it in 8 quarters. The position peaked at $29.4K in Q2 2021. 66 funds tracked by Wall St. Rank hold XPH as of Q3 2022.

Archer Investment Corporation reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
Archer Investment Corporation sold 570 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2022, an estimated $23.9K.
Archer Investment Corporation first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2020 and held it in 8 quarters.
Archer Investment Corporation's State Street SPDR S&P Pharmaceuticals ETF position peaked at $29.4K in Q2 2021.
66 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2022.

Based on Archer Investment Corporation's 13F filing for Q3 2022, filed 9 Nov 2022.